Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities

Published:2022-12 Issue: Volume:240 Page:108300
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Kaur Tejinder,Weadick Brenna,Mace Thomas A.,Desai Kajal,Odom Hannah,Govindarajan Rajgopal

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference363 articles.

1. Dipyridamole induces the phosphorylation of CREB to promote cancer cell proliferation;Abdelghany;Oncology Letters,2021

2. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia;Abraham;Pharmacogenomics,2015

3. Tumor macrophages are pivotal constructors of tumor collagenous matrix;Afik;The Journal of Experimental Medicine,2016

4. The resurgence of A2B adenosine receptor signaling;Aherne;Biochimica et Biophysica Acta,2011

5. Decreased equilibrative nucleoside transporter 1 (ent1) activity contributes to the high extracellular adenosine levels in mesenchymal glioblastoma stem-like cells;Alarcon;Cells,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment advances in high-grade gliomas;Frontiers in Oncology;2024-04-10

2. Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation;Translational Research;2024-01

3. Cancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer;Cell Death & Disease;2023-12-08

4. Novel Adenosine Receptor Antagonists for Treating Cancer and Immune-Related Disorders;ACS Medicinal Chemistry Letters;2023-11-08

5. Cross-species gene expression patterns of purinergic signaling in the human and mouse trigeminal ganglion;Life Sciences;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3